title: Atheroma of the aortic arch: the missing link in the secondary prevention of stroke?
abstract: Atheroma of the aortic arch is an important risk factor for stroke and for recurrent stroke. Optimal management is not known but these patients should probably receive more powerful antiplatelet treatment than aspirin alone. Whether combination treatment with aspirin plus clopidogrel is more effective than warfarin alone is the subject of the ongoing ARCH study.
authors.forename: M R
authors.initials: MR
authors.lastname: Macleod
authors.forename: G A
authors.initials: GA
authors.lastname: Donnan
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001013:Aorta, Thoracic; D001161:Arteriosclerosis / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D017548:Echocardiography, Transesophageal; D004691:Endarterectomy; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D012307:Risk Factors; D055502:Secondary Prevention; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors